Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1973 1
1974 5
1975 5
1976 7
1977 9
1978 15
1979 5
1980 13
1981 9
1982 10
1983 8
1984 14
1985 11
1986 9
1987 8
1988 12
1989 3
1990 5
1991 4
1992 2
1993 7
1994 2
1995 7
1996 13
1997 8
1998 13
1999 11
2000 21
2001 14
2002 8
2003 20
2004 14
2005 9
2006 12
2007 8
2008 8
2009 4
2010 4
2011 7
2012 10
2013 12
2014 4
2015 4
2016 2
2017 4
2018 4
2019 2
2020 4
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Results by year

Filters applied: . Clear all
Page 1
A double-blind controlled clinical trial of carnidazole and tinidazole in the treatment of vaginal trichomoniasis.
Chaudhuri P, Drogendijk AC. Chaudhuri P, et al. Eur J Obstet Gynecol Reprod Biol. 1980 Jun;10(5):325-8. doi: 10.1016/0028-2243(80)90080-5. Eur J Obstet Gynecol Reprod Biol. 1980. PMID: 6995193 Clinical Trial.
A double-blind controlled clinical trial of the new, not yet commercially available drug, carnidazole and tinidazole, was carried out in 77 women with a proven vaginal trichomoniasis. 39 patients and their sexual partners received a single dose of 2 g of carnidazole and th …
A double-blind controlled clinical trial of the new, not yet commercially available drug, carnidazole and tinidazole, was carried out …
Clinical Pharmacokinetics of Levornidazole in Elderly Subjects and Dosing Regimen Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis.
Guo B, He G, Wu X, Yu J, Cao G, Li Y, Fan Y, Chen Y, Shi Y, Zhang Y, Zhang J. Guo B, et al. Clin Ther. 2017 Jul;39(7):1336-1346. doi: 10.1016/j.clinthera.2017.05.350. Epub 2017 Jun 12. Clin Ther. 2017. PMID: 28619503 Clinical Trial.
PURPOSE: Levornidazole, the levo-isomer of ornidazole, is a third-generation nitroimidazole derivative newly developed after metronidazole, tinidazole, and ornidazole. An open-label, parallel-controlled, single-dose study was conducted for the investigation of the pharmaco …
PURPOSE: Levornidazole, the levo-isomer of ornidazole, is a third-generation nitroimidazole derivative newly developed after metronidazole, …
Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial.
Metanat HA, Valizadeh SM, Fakheri H, Maleki I, Taghvaei T, Hosseini V, Bari Z. Metanat HA, et al. Helicobacter. 2015 Aug;20(4):299-304. doi: 10.1111/hel.12202. Epub 2015 Mar 4. Helicobacter. 2015. PMID: 25752357 Clinical Trial.
One hundred and thirty-four patients received 10-day hybrid regimen (PACT-10): pantoprazole, 40 mg, and amoxicillin, 1 g, both twice daily for 10 days; plus clarithromycin, 500 mg, and tinidazole, 500 mg, both twice daily just during the last 5 days. One hundred and thirty …
One hundred and thirty-four patients received 10-day hybrid regimen (PACT-10): pantoprazole, 40 mg, and amoxicillin, 1 g, both twice daily f …
A randomized clinical study on the efficacy of vonoprazan combined with amoxicillin duo regimen for the eradication of Helicobacter pylori.
Yang F, Yu B, Qin L, Dai X. Yang F, et al. Medicine (Baltimore). 2023 Oct 13;102(41):e35610. doi: 10.1097/MD.0000000000035610. Medicine (Baltimore). 2023. PMID: 37832048 Free PMC article. Clinical Trial.
Group B: vonoprazan (20 mg) bid + amoxicillin (1 g) tid, duration of treatment is 10 days, group C: rabeprazole (20 mg) bid + bismuth potassium citrate tablets/tinidazole tablets/clarithromycin tablets, combined package (4.2 g), bid, duration of treatment 14 days. ...
Group B: vonoprazan (20 mg) bid + amoxicillin (1 g) tid, duration of treatment is 10 days, group C: rabeprazole (20 mg) bid + bismuth potass …
Prophylactic use of phenoxymethylpenicillin and tinidazole in mandibular third molar surgery, a comparative placebo controlled clinical trial.
Happonen RP, Bäckström AC, Ylipaavalniemi P. Happonen RP, et al. Br J Oral Maxillofac Surg. 1990 Feb;28(1):12-5. doi: 10.1016/0266-4356(90)90003-4. Br J Oral Maxillofac Surg. 1990. PMID: 2108712 Clinical Trial.
A clinical double-blind placebo controlled trial was carried out in 136 patients to test the value of the prophylactic use of phenoxymethylpenicillin and tinidazole in mandibular third molar surgery. The three patient groups were uniform with regard to the background data …
A clinical double-blind placebo controlled trial was carried out in 136 patients to test the value of the prophylactic use of phenoxymethylp …
Sequential Helicobacter pylori eradication therapy in Myanmar; a randomized clinical trial of efficacy and tolerability.
Myint NPST, Zaw TT, Sain K, Waiyan S, Danta M, Cooper D, Aung NM, Kyi MM, Hanson J. Myint NPST, et al. J Gastroenterol Hepatol. 2020 Apr;35(4):617-623. doi: 10.1111/jgh.14942. Epub 2019 Dec 5. J Gastroenterol Hepatol. 2020. PMID: 31758571 Clinical Trial.
Those testing positive were randomized 1:1 to receive receive Myanmar's first-line regimen of 14 days of concomitant rabeprazole, clarithromycin, amoxycillin and tinidazole (140 pills, cost US$23) or 10 days of sequential rabeprazole, clarithromycin, amoxycillin and tin
Those testing positive were randomized 1:1 to receive receive Myanmar's first-line regimen of 14 days of concomitant rabeprazole, clarithrom …
Combination of antimicrobials for non-specific isolated terminal ileal abnormalities - A randomized clinical trial.
Kumar R, Nath P, Anand AC, Misra P, Devisetty VJ, Tiwari A, Praharaj DL, Mallick B, Panigrahi SC, Acharya SK. Kumar R, et al. Indian J Gastroenterol. 2023 Oct;42(5):658-667. doi: 10.1007/s12664-023-01398-w. Epub 2023 Aug 28. Indian J Gastroenterol. 2023. PMID: 37639195 Clinical Trial.
METHODOLOGY: A pilot randomized clinical trial comparing combination antimicrobial therapy (oral Rifaximin 550 mg twice daily for two weeks; Albendazole 400 mg orally as a single dose; Tinidazole 1 gm twice daily for three days i.e. Group A) with symptomatic treatment (Gro …
METHODOLOGY: A pilot randomized clinical trial comparing combination antimicrobial therapy (oral Rifaximin 550 mg twice daily for two weeks; …
Clinical trial of prophylaxis of wound sepsis in elective colorectal surgery. Cephamandole with tinidazole versus tinidazole alone.
[No authors listed] [No authors listed] Med J Aust. 1983 Oct 29;2(9):440-3. Med J Aust. 1983. PMID: 6355795 Clinical Trial.
Two hundred and eleven patients were studied, of whom 100 received tinidazole and cephamandole, and 111 received tinidazole and a placebo. Wound infection occurred in 7% of the tinidazole/cephamandole group and in 9% of the tinidazole/placebo group (P …
Two hundred and eleven patients were studied, of whom 100 received tinidazole and cephamandole, and 111 received tinidazole an …
Comparison between  daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled  trial.
Shahbazi S, Vahdat Shariatpanahi Z. Shahbazi S, et al. Indian J Gastroenterol. 2018 Nov;37(6):550-554. doi: 10.1007/s12664-018-0916-z. Epub 2019 Jan 12. Indian J Gastroenterol. 2018. PMID: 30635887 Clinical Trial.
METHODS: In the study group, 105 patients received esomeprazole 40 mg, tinidazole 1 g, and levofloxacin 500 mg once-daily for 14 days. One hundred and seven patients in the control group received lansoprazole 30 mg, amoxicillin 1 g, and clarithromycin 500 mg twice-daily fo …
METHODS: In the study group, 105 patients received esomeprazole 40 mg, tinidazole 1 g, and levofloxacin 500 mg once-daily for 14 days …
A randomized trial comparing a polyherbal pessary (a complementary and alternative medicine) with Ginlac-V pessary (containing clotrimazole, tinidazole and lactobacilli) for treatment of women with symptomatic vaginal discharge.
Patel Y, Gopalan S, Bagga R, Sharma M, Chopra S, Sethi S. Patel Y, et al. Arch Gynecol Obstet. 2008 Oct;278(4):341-7. doi: 10.1007/s00404-008-0568-9. Epub 2008 Jan 31. Arch Gynecol Obstet. 2008. PMID: 18236058 Clinical Trial.
AIM: To compare the efficacy of two such agents: Praneem polyherbal pessary; a complementary and alternative medicine (CAM) with Ginlac-V pessary (containing clotrimazole, tinidazole and lactobacilli) for treatment of abnormal vaginal discharge. ...
AIM: To compare the efficacy of two such agents: Praneem polyherbal pessary; a complementary and alternative medicine (CAM) with Ginlac-V pe …
393 results